Clinical trials / Eating disorders
Recruiting psychedelic and ketamine trials for eating disorders
3 trials registered on ClinicalTrials.gov were recruiting on 26 Oct 2026, 2 of them at sites in the United States (2 states). By substance: Psilocybin 2, MDMA 1.
From the ClinicalTrials.gov registry (US National Library of Medicine), read through its public API on 26 Oct 2026: studies marked as recruiting whose interventions name the substance. Titles, sponsors, phases, conditions and sites are the registry's own entries, written by the sponsors. We have not vetted any trial, and recruiting status changes; the registry record and the study team have the current eligibility rules.
Trials with US sites
Phase 2PsilocybinNCT06399263
Study of Psilocybin for Anorexia in Young Adults (SPANYA)
- Conditions:
- Anorexia Nervosa
- Sponsor:
- Marissa Raymond-Flesch, MD, MPH
- Who:
- ages 18 Years to 25 Years, 40 participants planned
- University of California, San Francisco, San Francisco, California (not yet recruiting)
- University of California, San Francisco, San Francisco, California
Phase 1MDMANCT07542145
MDMA Assisted Therapy for BN
- Conditions:
- Bulimia Nervosa
- Sponsor:
- Icahn School of Medicine at Mount Sinai
- Who:
- ages 18 Years and over, 40 participants planned
- Department of Psychiatry, Eating and Weight Disorders Program, New York, New York
Trials outside the United States
Phase 2PsilocybinNCT07169747
Safety, Therapeutic Potential, and Mechanisms of Two Psilocybin Doses, Administered With Psychological Support in Young Adults With Anorexia Nervosa (psiAN)
- Conditions:
- Anorexia Nervosa
- Sponsor:
- Region Skane
- Who:
- ages 16 Years to 35 Years, 40 participants planned
- Where:
- Sweden